In this UCSF Department of Medicine Covid Grand Rounds, we’ll begin with a discussion of the new vaccine candidates. Just in the past few weeks, we’ve seen new data regarding several vaccines, including J&J, AstraZeneca, and Novavax. Dr. Monica Gandhi will review these new data, and discuss the implications for vaccine supply – and why it’s appropriate to be optimistic about vaccines, even in the face of a sluggish roll-out and the threat of variants. She’ll add a few thoughts about whether vaccinated people can change behavior. Dr. Marguerita Lightfoot then shares insights regarding communicating about vaccines – particularly to communities of color. Finally, Drs. Robert Rodriguez and Eric Goosby describe their experience as members of the Biden Covid-19 Task Force, which guided the early days of the new administration’s response to the pandemic. The session is moderated by UCSF Department of Medicine chair Bob Wachter.
00:06:14-00:34:50 – The New Vaccines: Monica Gandhi, MD, MPH (Professor of Medicine; Associate Chief of Division of HIV, Infectious Diseases, and Global Medicine at ZSFG; Director of the UCSF-Gladstone Center for AIDS Research; and Medical Director of the HIV Clinic, Ward 86, ZSFG)
00:34:54-00:39:28 – Q&A with Monica Gandhi
00:39:34-00:51:52 – Q&A with Marguerita Lightfoot, PhD (Professor of Medicine; Chief of Division of Prevention Science; Director of the Center for AIDS Prevention Studies and Prevention Research Center)
The New Vaccines
00:52:02-01:15:27 – President Biden’s Covid-19 Task Force: Eric Goosby, MD (Professor of Medicine; UN Special Envoy on Tuberculosis; Member of President Biden’s Covid-19 Task Force) and Robert Rodriguez, MD (Professor of Emergency Medicine; Member of President Biden’s Covid-19 Task Force)